BioBreakthroughs

Join us on the latest episode! Our Guest: Pascal Touchon, President and CEO at Atara Biotherapeutics

What you'll get out of this episode:

- Backstory on Pascal
- Leading CAR-T at Novartis and Atara, focusing on lymphoma.
- Creation of EBV T Cell Platform for cancer and autoimmune diseases.
- The milestones for Ebalo, including European approval.
- Impacting cell therapy with validation, quality manufacturing.
- Planned future directions, including FDA alignment and partnerships.


To learn more about Atara Biotherapeutics: https://www.atarabio.com/

Our sponsors for this episode are:
Sage Growth Partners https://sage-growth.com/
FlipMD by GoodRX https://www.goodrx.com/
Quantum Health https://quantum-health.com/

What is BioBreakthroughs?

Welcome to BioBreakthroughs, the podcast that delves deep into the world of biotech and pharmaceuticals to bring you the latest and most exciting advancements in the field. Join us as we explore groundbreaking discoveries, cutting-edge research, and game-changing innovations that are shaping the future of healthcare. Produced by Slice of Healthcare.